Vasomotor Rhinitis in a Competitive Athlete Subject to Anti-Doping Regulations

Managing vasomotor rhinitis in a competitive athlete requires particular attention to anti-doping requirements. Treatment choices must be compatible with the applicable prohibited-substance framework while still achieving adequate symptom control.

Clinical scenario

This protocol addresses vasomotor rhinitis in a competitive athlete who is subject to anti-doping regulations. The stepwise approach to managing rhinitis in athletes is consistent with that used in the general population, but must account for substance restrictions that apply in competition and out-of-competition periods.

Treatment approach

The structured regimen for this scenario involves topical agents used on a short-term, empiric basis. The full protocol — including the specific agent class, sequencing, and the anti-doping considerations guiding selection — is available via the link below.

Full regimen details, sequencing, and compliance guidance are in the complete protocol.

Instant Access to Structured Evidence-Based Regimens

References

The stepwise approach to manage athletes should be the same as that used with other populations.

Empiric short-term treatment with topical decongestants may be considered if these agents fail.

View source ↗